About the Authors
- Joshua M. Shulman
-
Affiliations Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America
- Lori B. Chibnik
-
Affiliations Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America
- Cristin Aubin
-
Affiliations Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America
- Julie A. Schneider
-
Affiliations Department of Pathology, Rush University Medical Center, Chicago, Illinois, United States of America, Rush Alzheimer's Disease Center, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, United States of America
- David A. Bennett
-
Affiliation Rush Alzheimer's Disease Center, Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, United States of America
- Philip L. De Jager
-
* E-mail: pdejager@rics.bwh.harvard.edu
Affiliations Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America, Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts, United States of America
Competing Interests
JMS is supported by by the Clinical Investigator Training Program: Beth Israel Deaconess Medical Center and Harvard/MIT Health Sciences and Technology, in collaboration with Pfizer Inc. and Merck & Co. This fellowship program is administered by academic institutions (Harvard/MIT/BIDMC), and supported by unrestricted commercial grants. This does not alter the authors' adherence to PLoS ONE policies on sharing data and materials. There are no other competing interests to declare.
Author Contributions
Conceived and designed the experiments: JMS JAS DB PLDJ. Performed the experiments: JMS CA. Analyzed the data: JMS LBC. Contributed reagents/materials/analysis tools: CA JAS DB. Wrote the paper: JMS LBC JAS DB PLDJ.